Research Store

Research Store

Research Store
add to cart Register yourself and then log-in with your user ID and password, before clicking on 'Add to Cart'
Issue Date:18 January 2017     Price in Rs. R 6500    Price in USD. $ 100

Pune based Emcure Pharma is among the largest unlisted pharma companies in India. Emcure was ranked 21st  in the Indian formulation market for 2016, with revenues of around Rs  1660 crore. Emcure has a market share of 1.6% in the highly fragmented domestic formulations market. Its key therapeutics areas are cardiology, pain and analgesics, HIV, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients.


Additionally, Emcure gets more than two-thirds of total revenues from the export market, where it exports to more than 60 countries. The company has aggressively targeted the North America market, where it has done acquisitions in the USA (2011) and Canada (2016).


PE fund Bain Capital is an investor in Emcure; it bought out Blackstone in 2013.  In 2006, Blackstone invested nearly $50 million in Emcure.

  • Company Background
  • Business Highlights
  • Financial Performance
  • Financial Details


  • Board of Directors
  • Financial Summary
  • Profit & Loss Account
  • Balance Sheet
  • Ratios


No data to display